PRO-CTCAE Analysis of Mobocertinib in EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC)

被引：0

作者：

Garcia Campelo, M. R. ^{[1
]}

Zhou, C. ^{[2
]}

Ramalingam, S. S. ^{[3
]}

Lin, H. M. ^{[4
]}

Kim, T. M. ^{[5
]}

Riely, G. J. ^{[6
]}

Mekhail, T. ^{[7
]}

Nguyen, D. ^{[8
]}

Biber, J. ^{[9
]}

Romero, H. ^{[4
]}

Goodman, E. ^{[4
]}

Popat, S. ^{[10
,11
]}

Janne, P. A. ^{[12
]}

机构：

[1] Complejo Hosp Univ A Coruna, La Coruna, Spain

[2] Shanghai Pulm Hosp, Shanghai, Peoples R China

[3] Emory Univ, Atlanta, GA USA

[4] Takeda Dev Ctr Amer Inc, Lexington, MA USA

[5] Seoul Natl Univ Hosp, Seoul, South Korea

[6] Mem Sloan Kettering Canc Ctr, New York, NY USA

[7] AdventHealth, Orlando, FL USA

[8] City Hope Natl Med Ctr, Los Angeles, CA USA

[9] Xcenda LLC, Carrollton, TX USA

[10] Royal Marsden Hosp, London, England

[11] Inst Canc Res, London, England

[12] Dana Farber Canc Inst, Boston, MA USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期

关键词：

non-small cell lung cancer; exon20; insertion; patient-reported outcomes;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP08.02-17

引用

页码：S487 / S488

页数：2

共 50 条

[1] Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis
Illini, Oliver
Saalfeld, Felix Carl
Christopoulos, Petros
Duruisseaux, Michael
Vikstroem, Anders
Peled, Nir
Demedts, Ingel
Dudnik, Elizabeth
Eisert, Anna
Hashemi, Sayed M. S.
Janzic, Urska
Kian, Waleed
Mohorcic, Katja
Mohammed, Saara
Silvoniemi, Maria
Rothschild, Sacha I.
Schulz, Christian
Wesseler, Claas
Addeo, Alfredo
Armster, Karin
Itchins, Malinda
Ivanovic, Marija
Kauffmann-Guerrero, Diego
Koivunen, Jussi
Kuon, Jonas
Pavlakis, Nick
Piet, Berber
Sebastian, Martin
Velthaus-Rusik, Janna-Lisa
Wannesson, Luciano
Wiesweg, Marcel
Wurm, Robert
Albers-Leischner, Corinna
Aust, Daniela E.
Janning, Melanie
Fabikan, Hannah
Herold, Sylvia
Klimova, Anna
Loges, Sonja
Sharapova, Yana
Schuetz, Maret
Weinlinger, Christoph
Valipour, Arschang
Overbeck, Tobias Raphael
Griesinger, Frank
Jakopovic, Marko
Hochmair, Maximilian J.
Wermke, Martin
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
[2] Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer
Gao, Xin
Wei, Xue-Wu
Zheng, Ming-Ying
Chen, Zhi-Hong
Zhang, Xu-Chao
Zhong, Wen-Zhao
Yang, Jin-Ji
Wu, Yi-Long
Zhou, Qing
[J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 5822 - +
[3] Mechanisms of resistance to mobocertinib in EGFR exon 20 insertion-mutant non-small cell lung cancer (NSCLC)
Park, S.
Kim, T. M.
Kim, S.
Kim, M.
Keam, B.
Kim, D. W.
Heo, D. S.
[J]. EUROPEAN JOURNAL OF CANCER, 2022, 174 : S110 - S111
[4] FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Duke, Elizabeth S.
Stapleford, Liza
Drezner, Nicole
Amatya, Anup K.
Mishra-Kalyani, Pallavi S.
Shen, Yuan -Li
Maxfield, Kimberly
Zirkelbach, Jeanne Fourie
Bi, Youwei
Liu, Jiang
Zhang, Xinyuan
Wang, Hezhen
Yang, Yuching
Zheng, Nan
Reece, Kelie
Wearne, Emily
Glen, Jacqueline J.
Ojofeitimi, Idara
Scepura, Barbara
Nair, Abhilasha
Bikkavilli, Rama Kamesh
Ghosh, Soma
Philip, Reena
Pazdur, Richard
Beaver, Julia A.
Singh, Harpeet
Donoghue, Martha
[J]. CLINICAL CANCER RESEARCH, 2023, 29 (03) : 508 - 512
[5] Targeting EGFR Exon 20 Insertion Mutation in Non-small cell Lung Cancer: Amivantamab and Mobocertinib
Russell, Molly C.
Garelli, Alyssa M.
Reeves, David J.
[J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (02) : 198 - 206
[6] Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer
Yang, James Chih-Hsin
Zhou, Caicun
Janne, Pasi A.
Ramalingam, Suresh S.
Kim, Tae Min
Riely, Gregory J.
Spira, Alexander, I
Piotrowska, Zofia
Mekhail, Tarek
Campelo, Maria Rosario Garcia
Felip, Enriqueta
Bazhenova, Lyudmila
Jin, Shu
Kaur, Manmit
Diderichsen, Paul M.
Gupta, Neeraj
Bunn, Veronica
Lin, Jianchang
Churchill, Eric
Mehta, Minal
Nguyen, Danny
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (01) : 95 - 106
[7] A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer
van Veggel, Bianca A. M. H.
van der Wekken, Anthonie J.
Paats, Marthe S.
Hendriks, Lizza E. L.
Hashemi, Sayed M. S.
Daletzakis, Antonios
van den Broek, Daan
Bosch, Linda J. W.
Monkhorst, Kim
Smit, Egbert F.
de Langen, Adrianus J.
[J]. CANCER, 2024, 130 (05) : 683 - 691
[8] Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non-small cell lung cancer
Huang, Wei-Sheng
Li, Feng
Gong, Yongjin
Zhang, Yun
Youngsaye, Willmen
Xu, Yongjin
Zhu, Xiaotian
Greenfield, Matthew T.
Kohlmann, Anna
Taslimi, Paul M.
Toms, Angela
Zech, Stephan G.
Zhou, Tianjun
Das, Biplab
Jang, Hyun G.
Tugnait, Meera
Ye, Yihua E.
Gonzalvez, Francois
Baker, Theresa E.
Nadworny, Sara
Ning, Yaoyu
Wardwell, Scott D.
Zhang, Sen
Gould, Alexandra E.
Hu, Yongbo
Lane, Weston
Skene, Robert J.
Zou, Hua
Clackson, Tim
Narasimhan, Narayana I.
Rivera, Victor M.
Dalgarno, David C.
Shakespeare, William C.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 80
[9] EGFR exon 20 insertion mutations in non-small cell lung cancer
Wang, Fenfang
Li, Chenghui
Wu, Qihuan
Lu, Hongyang
[J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
[10] Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer
Gonzalvez, Francois
Vincent, Sylvie
Baker, Theresa E.
Gould, Alexandra E.
Li, Shuai
Wardwell, Scott D.
Nadworny, Sara
Ning, Yaoyu
Zhang, Sen
Huang, Wei-Sheng
Hu, Yongbo
Li, Feng
Greenfield, Matthew T.
Zech, Stephan G.
Das, Biplab
Narasimhan, Narayana, I
Clackson, Tim
Dalgarno, David
Shakespeare, William C.
Fitzgerald, Michael
Chouitar, Johara
Griffin, Robert J.
Liu, Shengwu
Wong, Kwok-Kin
Zhu, Xiaotian
Rivera, Victor M.
[J]. CANCER DISCOVERY, 2021, 11 (07) : 1672 - 1687

← 1 2 3 4 5 →